Tilray reported a net revenue of $821 million for the fiscal year, with strategic decisions impacting revenue by $35 million. Q4 consolidated adjusted EBITDA was the 2nd highest in the company’s history. International cannabis revenue increased by 71% in Q4 and 19% for the fiscal year. Canadian cannabis remained #1 by revenue for the fiscal year.

Tilray saw a 19% revenue growth in beverages, totaling $241 million for the fiscal year. Additionally, there was a 9% revenue growth in wellness, reaching $60 million for the fiscal year. The company has a strong balance sheet with $256 million available in cash and marketable securities and has made total debt repayments of ~$100 million to date.

For the fiscal year 2026, Tilray expects adjusted EBITDA to be between $62 million to $72 million, representing growth of 13% to 31% compared to fiscal year 2025. The company is focused on key growth opportunities in cannabis, beverages, and wellness, with a commitment to innovation and driving growth by delivering innovative new products.

Read more at GlobeNewswire: Tilray Brands Reports Fourth Quarter and Fiscal 2025